Innovación en medicamentosefectos para el "cliente" público y cambios legislativos recientes

Abstract

This paper analyse the research and development process of the drugs to put it on relationship to the degree and type of innovation that it suppose. The capacity of the innovative drugs to satisfy the sanitary needs must be related to the cost and the necessary effort to reach those innovations, but also with the capacity of the health systems to support the costs of a pharmaceutical service based on a competitive dynamics of continuous innovations protected by patent, by so much with power of market of the laboratories that market them. The role of the Spanish administrations as regulatory and as health service is analyzed after those problems, related with the main decisions that they have of taking, the fixing of prices and the incorporation in the public presentation. In this sense are checked the main economic aspects of the recent Act of Guarantees and Rational Use of the Medicine and the Sanitary Products